Ignite Creation Date:
2024-05-05 @ 11:13 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01280747
Status:
TERMINATED
Last Update Posted:
2021-01-26
First Post:
2011-01-19
Brief Title:
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders the ExPAND Study
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
A0081247
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None